This inventor holds 4 USPTO granted patents. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1991-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-2008
Title: Innovations of Yoshimi Wakai
Introduction
Yoshimi Wakai is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of antifungal treatments, holding a total of 4 patents. His work focuses on the development of innovative combinations of antifungal agents that enhance treatment efficacy.
Latest Patents
Wakai's latest patents include a therapeutic combination of a pneumocandin derivative and an antifungal agent. This invention describes the use of known antifungal agents, such as azoles or polyenes, in combination with a lipopeptide compound antifungal agent. More specifically, it relates to the antifungal combination use of azoles like fluconazole, voriconazole, itraconazole, ketoconazole, miconazole, ER 30346, and SCH 56592; polyenes such as amphotericin B, nystatin, and their liposomal forms like Abelcet, AmBisome, and Amphocil; as well as purine or pyrimidine nucleotide inhibitors like flucytosine. Additionally, it includes polyoxins such as nikkomycins, particularly nikkomycin Z or nikkomycin X, and other chitin inhibitors. Another patent involves the combination of a cyclic hexapeptide with antifungal drugs for the treatment of fungal pathogens, utilizing similar known antifungal agents.
Career Highlights
Throughout his career, Yoshimi Wakai has worked with prominent companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in developing effective antifungal treatments.
Collaborations
Wakai has collaborated with several professionals in his field, including Yoshiko Yokota and Yasuhiro Mine. These collaborations have likely enriched his research and development efforts in antifungal therapies.
Conclusion
Yoshimi Wakai's innovative work in antifungal treatments showcases his dedication to improving healthcare solutions. His patents reflect a commitment to advancing medical science and providing effective therapies for fungal infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile